Evolent Health, Inc.
EVH · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $965 | $1,305 | $1,092 | $1,294 |
| - Cash | $117 | $151 | $247 | $104 |
| + Debt | $27 | $205 | $870 | $714 |
| Enterprise Value | $876 | $1,359 | $1,716 | $1,904 |
| Revenue | $480 | $444 | $484 | $647 |
| % Growth | 7.9% | -8.1% | -25.2% | – |
| Gross Profit | $100 | $100 | $102 | $76 |
| % Margin | 20.8% | 22.6% | 21.2% | 11.7% |
| EBITDA | $15 | $13 | -$29 | $13 |
| % Margin | 3% | 2.9% | -5.9% | 2.1% |
| Net Income | -$21 | -$20 | -$65 | -$23 |
| % Margin | -4.4% | -4.5% | -13.4% | -3.5% |
| EPS Diluted | -0.24 | -0.44 | -0.63 | -0.27 |
| % Growth | 45.5% | 30.2% | -133.3% | – |
| Operating Cash Flow | $16 | -$30 | $5 | -$26 |
| Capital Expenditures | -$9 | -$9 | -$9 | -$6 |
| Free Cash Flow | $7 | -$39 | -$4 | -$32 |